Please provide your email address to receive an email when new articles are posted on . The FDA launched a new online dashboard for reporting adverse events related to cosmetic products. This ...

Preeclampsia, gestational hypertension, and other adverse pregnancy outcomes (APOs) are known predictors of worse cardiovascular health later in life, but a new mendelian randomization study suggests ...

A large U.S. cohort-crossover study found that pregnancy and the postpartum period were linked to about a seven-fold higher relative risk of major adverse cardiovascular events compared with patients’ ...

The FDA Adverse Event Reporting System (FAERS) contains reports from health care professionals, consumers, and manufacturers on adverse events, serious medication errors, and product quality ...

The U.S. Food and Drug Administration is now providing real-time, daily publication updates on adverse event data from its reporting system. In an effort to modernize and provide transparency on ...

Please provide your email address to receive an email when new articles are posted on . The FDA Adverse Event Reporting System will now host daily publications, instead of quarterly. The agency’s goal ...

Access to patient-reported outcome (PRO) data significantly improved providers' consistency in assessing adverse events in patients with cancer, with the greatest improvements observed for ...

It’s out with the old, in with the new at the FDA as the agency is unveiling a new adverse events monitoring system that joins several reporting systems into one unified platform, an effort that’s ...

The FDA has received hundreds of adverse event reports after people used compounded GLP-1 drugs for weight loss. Compounded GLP-1 drugs aren’t reviewed by the FDA for safety or effectiveness. The FDA ...

The US Food and Drug Administration (FDA) announced it is unifying its various adverse reporting systems into a single system called the Adverse Event Monitoring System (AEMS). The agency said the ...